Breaking News
Danaher to buy Pall Corporation for $14bn
Pall has agreed to be acquired by Danaher Corporation for $13.8bn (€12bn).
Archives for May 12, 2015
SAFC expands ADC and bulk drug manufacturing in CA, MO
SAFC has announced investments in gene therapy manufacturing sites in Missouri and California.
Alexion growing biologics network through €450m Irish plant
Alexion will expand its manufacturing network with a €450m ($507m) biologics facility in Ireland, a week after entering an $8.4bn agreement to acquire Synageva.